Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 214
-2
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are climate change and air pollution triggering cardiovascular disease?

    Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

    A robust and clinical-friendly CRISPR diagnostic test kit for rapid SARS-COV2 detection

    The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of...

    Can cattle ventilate effectively while tilted in a chute and receiving veterinary care?

    Cattle are commonly presented to veterinarians for routine and emergent medical procedures. Lower limbs...

    Backer Badge Funded